Vascular Disease
Schering-Plough Reports Two Phase II Studies of Thrombin Receptor Antagonist (TRA) Build on Findings from Previous Phase II Study
Published in Cardiovascular Week, November 5th, 2007
Schering-Plough Corporation (NYSE:SGP) today provided an update on the clinical development program for its novel oral thrombin receptor antagonist (TRA). Results from two randomized, double-blind, placebo-controlled Phase II studies in patients with vascular disease showed that TRA does not increase the rate of major or minor bleeding in patients with acute coronary syndrome or prior ischemic stroke when added to standard antiplatelet therapy. The trials were conducted in Japan as part of the global registration program for TRA.
"These findings confirm the results of the TRA-PCI Phase II trial, which were presented at the American College of Cardiology/i2 Summit...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2007-11-05)
More Articles from Cardiovascular Week
- Erectile Dysfunction
Have a Smoke-Free Holiday - Abdominal Aortic Aneurysm
Data from E.H. Murphy et al provide new insights into abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Findings from C. Klonaris et al in abdominal aortic aneurysm reported - Abdominal Aortic Aneurysm
Studies by M.A. Sharif and co-authors describe new findings in abdominal aortic aneurysm - Aneurysm
Recent findings from C. Attia and co-authors highlight research in aneurysm - Aneurysm
Report summarizes aneurysm study findings from University of Ulsan - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
